Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1141-1148 , December 2008

What is new in ultrasound and magnetic resonance imaging for musculoskeletal disorders?

  • Marco A. Cimmino, MD (Associate Professor of Rheumatology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +39 010 3538905; Fax: +39 010 3538638.

References 

  1. Salaffi F, Filippucci E, Carotti M, et al. Inter-observer agreement of standard joint counts in early rheumatoid arthritis: a comparison with grey scale ultrasonography – a preliminary study. Rheumatology (Oxford). 2008;47:54–58
  2. Taylor PC, Steuer A, Gruber J, et al. Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year-delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis. Arthritis and Rheumatism. 2006;54:47–53
  3. Naredo E, Collado P, Cruz A, et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis and Rheumatism. 2007;57:116–124
  4. Balint PV, Mandl P, Kane D. ‘All that glistens is not gold’ – separating artefacts from true Doppler signals in rheumatological ultrasound. Annals of the Rheumatic Diseases. 2008;67:141–142
  5. Terslev L, von der Recke P, Torp-Pedersen S, et al. Diagnostic sensitivity and specificity of Doppler ultrasound in rheumatoid arthritis. The Journal of Rheumatology. 2008;35:49–53
  6. Filippucci E, Iagnocco A, Salaffi F, et al. Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab. Annals of the Rheumatic Diseases. 2006;65:1433–1437
  7. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gadofosveset trisodium: comparison to gadopentetate dimeglumine. Investigative Radiology. 2007;42:659–664
  8. Filippucci E, Meenagh G, Epis O, et al. Ultrasound imaging for the rheumatologist. XIII. New trends. Three-dimensional ultrasonography. Clinical and Experimental Rheumatology. 2008;26:1–4
  9. Meenagh G, Filippucci E, Abbattista T, et al. Three-dimensional power Doppler sonography in short-term therapy monitoring of rheumatoid synovitis. Rheumatology (Oxford). 2007;46:1736
  10. Filippucci E, Meenagh G, De Agustin JJ, et al. Level of agreement between rheumatologists on US image acquisition using a 3D volumetric probe. Clinical and Experimental Rheumatology. 2007;25:116
  11. Ju JH, Kang KY, Kim IJ, et al. Three-dimensional ultrasonographic application for analyzing synovial hypertrophy of the knee in patients with osteoarthritis. Journal of Ultrasound in Medicine. 2008;27:729–736
  12. Garra BS. Imaging and estimation of tissue elasticity by ultrasound. Ultrasound Quarterly. 2007;23:255–268
  13. Levinson SP, Shinagawa M, Sato T. Sonoelastic determination of human skeletal muscle elasticity. Journal of Biomechanics. 1995;28:1145–1154
  14. Silvestri E, Garlaschi G, Bartolini B, et al. Sonoelastography can help in the localization of soft tissue damage in polymyalgia rheumatica (PMR). Clinical and Experimental Rheumatology. 2007;25:796
  15. Lindegaard HM, Vallø J, Hørslev-Petersen K, et al. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study. Annals of the Rheumatic Diseases. 2006;65:1208–1212
  16. Schirmer C, Scheel AK, Althoff CE, et al. Diagnostic quality and scoring of synovitis, tenosynovitis and erosions in low-field MRI of patients with rheumatoid arthritis: a comparison with conventional MRI. Annals of the Rheumatic Diseases. 2007;66:522–529
  17. American College of Rheumatology Extremity Magnetic Imaging Task Force . Extremity magnetic resonance imaging in rheumatoid arthritis. Arthritis and Rheumatism. 2006;54:1034–1047
  18. Yocum DE, Conaghan PG, Olech E, Peterfy CG. Response: office-based low-field extremity magnetic resonance imaging: is the glass half empty or half full?. Arthritis and Rheumatism. 2006;54:1048–1050
  19. Hetland ML, Ejbjerg BJ, Hørslev-Petersen K, et al. MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2 year randomized controlled trial (CIMESTRA). Annals of the Rheumatic Diseases. 2008;67:815–822
  20. Kramer H, Quick HH, Tombach B, et al. Whole-body MRA. European Radiology. 2008;18:1925–1936
  21. Summers GD, Deighton CM, Rennie MJ, Booth AH. Rheumatoid cachexia: a clinical perspective. Rheumatology (Oxford). 2008;47:1124–1131
  22. Appel H, Hermann KG, Althoff CE, et al. Whole-body magnetic resonance imaging evaluation of widespread inflammatory lesions in a patient with ankylosing spondylitis before and after 1 year of treatment with infliximab. The Journal of Rheumatology. 2007;34:2497–2498

PII: S1521-6942(08)00108-3

doi: 10.1016/j.berh.2008.09.012

Best Practice & Research Clinical Rheumatology
Volume 22, Issue 6 , Pages 1141-1148 , December 2008

Article Tools

* Image Usage & Resolution